Ignite Creation Date:
2024-05-06 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05154994
Status:
SUSPENDED
Last Update Posted:
2024-06-18
First Post:
2021-11-30
Brief Title:
Tremelimumab DurvalumabMEDI4736 Belinostat in ARID1A Mutated Cancer Focus on Urothelial Carcinoma
Sponsor:
University of Utah
Organization:
University of Utah
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-30
First Submit QC Date:
December 10 2021
Study First Post Date:
2021-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL